Shin HC, Han W, Moon HG, Yom CK, Ahn SK, You JM, Kim JS, Chang JM, Cho N, Moon WK, Park IA, Noh DY. Limited Value and Utility of Breast MRI in Patients Undergoing Breast-Conserving Cancer Surgery. Ann Surg Oncol. 2012 Aug; 19(8):2572-9. doi: 10.1245/s10434-012-2289-3. Epub 2012 Mar 24.

Shin HC, Han W, Moon HG, Cho N, Moon WK, Park IA, Park SJ, Noh DY. Nomogram for predicting positive resection margins after breast-conserving surgery. Breast Cancer Res Treat. 2012 Aug; 134(3):1115-23. doi: 10.1007/s10549-012-2124-3. Epub 2012 Jun 13.

Shin HC, Han W, Moon HG, Moon WK, Park IA, Park SJ, Noh DY, Breast-Conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Ann Surg Oncol. 2013 Aug;20(8):2582-9. Doi: 10.1245/s10434-013-2909-6. Epub 2013 Mar 16.

Shin HC, Moon SB, Lee SC, Jung SE, Park KW, Experience with Enterostomy Closure in Very Low Birth Weight Infants. J Korean Assoc Pediatr Surg. 2009 Jun; 15(1): 18-26

Shin HC, Lee JH, Jee YS, Park DJ, Kim HH, Han HS, Laparoscopic Removal of a Vertebral Foreign Body. J Korean Soc Endosc Laparosc Surg. 2009 Jun; 12(1): 54-56

Kim JS, Moon HG, Ahn SK, Min JW, Shin HC, Kim HS, Yeom CK, Ha SW, Chie EK, Han W, Noh DY, Clinicopathological Characteristics and Factors Affecting Recurrence of Ductal Carcinoma In Situ in Korean Women. J Breast Cancer. 2010 Dec 13(4): 392-397

Kim HJ, Han W, Yi OV, Shin HC, Ahn SK, Koh BS, Moon HG, You JH, Son BH, Ahn SH, Noh DY, Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype. Breast Cancer Res Treat. 2011 Nov 130(2):499-505

Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY, Moon BI, Clinical Significance of Annexin A1 ex-pression in Breast Cancer. J Breast Cancer. 2011 Dec 14(4):262-268

Hwang GT, Woo JW, Shin HC, Kim HS, Ahn SK, Moon HG, Han W, Park IA, Noh DY, Prognostic influence of BCL2 ex-pression in breast cancer. Int J Cancer. 2012 Oct 1;131(7):E1109-13. doi: 10.1002/ijc.27539. Epub 2012 Apr 4.

Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, Moon HG, Cho N, Moon WK, Park IA, Noh DY, Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast. 2012 Oct; 21(5):641-5. Epub 2012 Jun 30.

Kim J, Han W, Moon HG, Ahn SK, Shin HC, You JM, Han SW, Im SA, Kim TY, Koo HR, Chang JM, Cho N, Moon WK, Noh DY, Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res. 2012 Jul 6;14(4):R102. Epub 2012 Jun 30.

Jung HJ, Han W, Moon HG, Ahn SK, Kim J, Noh DY, Chang JM, Cho N, Moon WK, Park IA, Shin HC, Sclerosing Adenosis Diagnosed by Needle Biopsy: Potential Safety of Follow-up by Observation Only. Korean J Clin Oncol. 2012;8(2): 85-91

Ahn SK, Moon HG, Ko E, Kim HS, Shin HC, Kim J, You JM, Han W, Noh DY, Preoperative serum tissue polypeptide-specific antigen is a valuable prognostic marker in breast cancer. Int J Cancer. 2012 Jul 19. doi: 10.1002/ijc.27727. Epub 2012 Sep 7.

Moon HG, Yi JK, Kim HS, Lee HY, Lee KM, Yi M, Ahn S, Shin HC, Ju JH, Shin I, Han W, Noh DY, Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer. BMC Cancer. 2012 Dec 10;12:585. doi: 10.1186/1471-2407-12-585

J Kim, HG Moon, SK Ahn, JW Min, HC Shin, HS Kim, CK, Yeom, SH Ha, EK, Chie, W Han, DY Noh, Clinicopathological Characteristics and Factors Affecting Recurrence of Ductal Carcinoma In Situ in Korean Women

Ryu HS, Park IA, Park SY, Jung YY, Park SH, Shin HC, A Pilot Study Evaluating Liquid-Based Fine Needle Aspiration Cytology of Breast Lesions: A Cytomorphological Comparison of SurePath® Liquid-Based Preparations and Conventional Smears. Acta Cytol. 2013 57(4):391-9. Doi: 10.1159/000351306. Epub 2013 Jul 12.

Shin HC, Choe JW, Ryu HS, Kim HS, Shin JW, Kim YS, Park SJ, Sarcoidosis Mimicking Metastatic Breast Cancer in Korean Woman with Breast Cancer. Breast J. 2014 Mar-Apr;20(2):198-9. doi: 10.1111/tbj.12245. [Epub ahead of print]

Kim J, Han W, Moon HG, Ahn SK, Shin HC, You JM, Chang JM, Cho N, Moon WK, Park IA, Noh DY, Low rates of additional cancer detection by magnetic resonance imaging in newly diagnosed breast cancer patients who underwent preoperative mammography and ultrasonography. J Breast Cancer. 2014 Jun;17(2)167-173. Epub 2014 Jun 27.

Lee ES, Han W, Shin HC, Takada M, Ryu HS, Cho N, Kim MK, Kim J, Yoo TK, Moon HG, Toi M, Moon WK, Park IA, Noh DY, Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery. Eur J Surg Oncol. 2016 Aug;42(8):1169-75.

Shin HC, Han W, Moon HG, Park IA, Noh DY. Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis. J Breast Cancer. 2016 Sep;19(3):268-274.

Shin HC, Relapse of Biphenotypic Acute Leukemia as a Breast Mass. J Breast Cancer. 2016 Dec;19(4):455-458.

Sohn HJ, Kim HS, Park SJ, Shin HC. Reliability of Core Needle Biopsy in Evaluating Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2, and Ki-67 Status. J Breast Dis. 2016;4(2):70-76

Kang HS, Han J, Kim J, Lee HB, Shin HC, Han W, Noh DY, Moon HG, Analysis of the Relationship between Body Mass Index and Breast Cancer Incidence in Korean Women, J Breast Dis. 2016;4(2): 64-69

Shin HK, Kim MK, Park SJ, Seok JW, Shin HC, Axillary Lymph Node to Primary Breast Tumor Standardized Uptake Value Ratio from FDG-PET/CT Imaging for Predicting the Necessity for Nodal Dissection in Primary Breast Tumors, J Breast Dis. 2017;5(2)76-81

Han J, Lee HB, Lee ES, Kang YJ, Kim Y, Choi J, Rhu J, Shin HC, Han W, Noh DY, Moon HG. The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities. PLoS One. 2017 Mar 21;12(3):e0173721. doi: 10.1371/journal.pone.0173721.

Yoo TK, Chang JM, Shin HC, Han W, Noh DY, Moon HG. An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment. BMC cancer. 2017 May 31;17(1):389. doi: 10.1186/s12885-017-3380-8.

Valachis A, Mamounas EP, Mittendorf EA, Hayashi N, Ishitobi M, Natoli C, Fitzal F, Rubio IT, Tiezzi DG, Shin HC, Anderson SJ, Hunt KK, Matsuda N, Ohsumi S, Totomi A, Nilsson C. Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis. Cancer. 2018 Jul 15;124(14): 2923-2930.

Kim HJ, Kim SM, Shin HC, Jang JS, Kim YI, Han DH, A Mobile Game for Patients With Breast Cancer for Chemotherapy Self-Management and Quality-of-Life Improvement: Randomized Controlled Trial. J Med Internet Res. 2018 Oct;20(10):e273 doi:10.2196/jmir.9559